Announced
Synopsis
GE HealthCare, a global medical technology, pharmaceutical diagnostics, and digital solutions innovator, agreed to acquire the remaining 50% stake in Nihon Medi-Physics, a pharmaceutical manufacturing firm, from Sumitomo Chemical, a major Japanese chemical company. Financial terms were not disclosed. As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.